Patent Expiration

PONVORY (ponesimod) Vanda pharms inc Patent: 8,273,779 Expiration: Dec 17, 2025 See More … For more information on how DrugPatentWatch […]

POMALYST (pomalidomide) Bristol Patent: 8,198,262 Expiration: Dec 17, 2025 See More … For more information on how DrugPatentWatch can help

NESINA (alogliptin benzoate) Takeda pharms usa Patent: 8,173,663 Expiration: Dec 2, 2025 See More … For more information on how

GOCOVRI (amantadine hydrochloride) Supernus pharms Patent: 8,796,337 Expiration: Nov 23, 2025 See More … For more information on how DrugPatentWatch

AIRDUO DIGIHALER (fluticasone propionate; salmeterol xinafoate) Teva pharm Patent: 10,765,820 Expiration: Nov 19, 2025 See More … For more information

INLYTA (axitinib) Pf prism cv Patent: 6,534,524 Expiration: Oct 29, 2025 See More … For more information on how DrugPatentWatch

TRUQAP (capivasertib) Astrazeneca Patent: 8,809,336 Expiration: Oct 25, 2025 See More … For more information on how DrugPatentWatch can help

BYDUREON (exenatide synthetic) Astrazeneca ab Patent: 8,461,105 Expiration: Oct 13, 2025 See More … For more information on how DrugPatentWatch

DAYTRANA (methylphenidate) Noven pharms inc Patent: 8,632,802 Expiration: Oct 7, 2025 See More … For more information on how DrugPatentWatch